Ferda Cevikbas

Ferda Cevikbas currently serves as Vice President and Head of Innovation for North America and Asia at LEO Pharma, a position held since November 2024. Prior experience includes serving as Executive Director and Head of Translational Sciences at ASLAN Pharmaceuticals from September 2021 to July 2024, and as Senior Clinical Research Advisor within the Translational Sciences and Evidence Creation Group at Eli Lilly and Company from October 2020 to September 2021. Ferda also held the position of Director for Translational Neuroscience and Dermatology at Dermira, Inc. from January 2017 to October 2020, focusing on developing medical therapies for skin conditions with an emphasis on neurogenic and neuro-inflammatory components. Earlier roles included Associate Director of Research, highlighting expertise in literature and research skills. Educational background includes a Master's Degree in Cell/Cellular and Molecular Biology from Westfaelische Wilhelms-Universitaet Muenster and studies at the University of California, San Francisco.